Aristotle Capital Management, LLC Abb Vie Inc. Transaction History

Aristotle Capital Management, LLC

$51.7 Billion
Q3 2024

A detailed history of Aristotle Capital Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Aristotle Capital Management, LLC holds 68,655 shares of ABBV stock, worth $13.1 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

68,655

Previous 68,655 -0.0%

Holding current value

$13.1 Million

Previous $11.8 Million 15.13%

% of portfolio

0.03%

Previous 0.02%

37 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$154.79 - $180.76 $11.3 Million - $13.2 Million	-73,248 Reduced 51.62%	68,655 $11.8 Million
Q1 2024 May 15, 2024	BUY	$159.82 - $182.1 $23,014 - $26,222	144 Added 0.1%	141,903 $25.8 Million
Q4 2023 Feb 14, 2024	BUY	$137.6 - $154.97 $10.2 Million - $11.4 Million	73,800 Added 108.59%	141,759 $22 Million
Q3 2023 Nov 14, 2023	SELL	$133.59 - $154.65 $136,261 - $157,743	-1,020 Reduced 1.48%	67,959 $10.1 Million
Q2 2023 Aug 14, 2023	SELL	$132.51 - $164.9 $903,055 - $1.12 Million	-6,815 Reduced 8.99%	68,979 $9.29 Million
Q1 2023 May 15, 2023	SELL	$144.61 - $166.54 $1.18 Million - $1.36 Million	-8,168 Reduced 9.73%	75,794 $12.1 Million
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $1.19 Million - $1.42 Million	8,579 Added 11.38%	83,962 $13.6 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $25,097 - $28,784	187 Added 0.25%	75,383 $10.1 Million
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $14,312 - $18,195	-104 Reduced 0.14%	75,196 $11.5 Million
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $13,197 - $16,375	-100 Reduced 0.13%	75,300 $12.2 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $1,181 - $1,495	11 Added 0.01%	75,400 $10.2 Million
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $11,916 - $13,527	112 Added 0.15%	75,389 $8.13 Million
Q2 2021 Aug 16, 2021	SELL	$105.21 - $117.21 $126,251 - $140,652	-1,200 Reduced 1.57%	75,277 $8.48 Million
Q1 2021 May 17, 2021	SELL	$102.3 - $112.62 $10,536 - $11,599	-103 Reduced 0.13%	76,477 $8.28 Million
Q4 2020 Feb 16, 2021	SELL	$80.49 - $108.67 $1,126 - $1,521	-14 Reduced 0.02%	76,580 $8.21 Million
Q3 2020 Nov 16, 2020	BUY	$85.91 - $100.83 $773 - $907	9 Added 0.01%	76,594 $6.71 Million
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $73 - $98	1 Added 0.0%	76,585 $7.52 Million
Q1 2020 May 15, 2020	SELL	$64.5 - $97.79 $179,310 - $271,856	-2,780 Reduced 3.5%	76,584 $5.84 Million
Q4 2019 Feb 14, 2020	SELL	$72.13 - $90.25 $1,081 - $1,353	-15 Reduced 0.02%	79,364 $7.03 Million
Q3 2019 Nov 14, 2019	SELL	$62.98 - $75.72 $268,420 - $322,718	-4,262 Reduced 5.1%	79,379 $6.01 Million
Q2 2019 Aug 14, 2019	SELL	$65.7 - $83.98 $41.7 Million - $53.3 Million	-635,257 Reduced 88.37%	83,641 $6.08 Million
Q1 2019 May 15, 2019	SELL	$77.14 - $90.79 $179 Million - $211 Million	-2,325,371 Reduced 76.39%	718,898 $57.9 Million
Q4 2018 Feb 14, 2019	SELL	$77.85 - $96.01 $33.5 Million - $41.3 Million	-430,667 Reduced 12.39%	3,044,269 $281 Million
Q3 2018 Nov 14, 2018	SELL	$88.91 - $98.84 $57.8 Million - $64.2 Million	-649,633 Reduced 15.75%	3,474,936 $329 Million
Q2 2018 Sep 19, 2019	SELL	$89.78 - $106.23 $6.02 Million - $7.12 Million	-67,000 Reduced 1.6%	4,124,569 $382 Million
Q2 2018 Aug 14, 2018	BUY	$89.78 - $106.23 $36.2 Million - $42.9 Million	403,696 Added 10.66%	4,191,569 $388 Million
Q1 2018 May 15, 2018	BUY	$92.01 - $123.21 $3.2 Million - $4.28 Million	34,727 Added 0.93%	3,787,873 $359 Million
Q4 2017 Feb 14, 2018	SELL	$89.56 - $98.21 $78.8 Million - $86.4 Million	-879,600 Reduced 18.99%	3,753,146 $363 Million
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $269,201 - $343,853	3,854 Added 0.08%	4,632,746 $412 Million
Q2 2017 Nov 16, 2017	BUY	N/A	102,269 Added 2.26%	4,628,892 $336 Million
Q1 2017 Nov 16, 2017	BUY	N/A	154,719 Added 3.54%	4,526,623 $295 Million
Q4 2016 Nov 16, 2017	BUY	N/A	176,116 Added 4.2%	4,371,904 $274 Million
Q3 2016 Nov 16, 2017	SELL	N/A	-48,523 Reduced 1.14%	4,195,788 $265 Million
Q2 2016 Nov 16, 2017	BUY	N/A	89,306 Added 2.15%	4,244,311 $263 Million
Q1 2016 Nov 17, 2017	BUY	N/A	133,367 Added 3.32%	4,155,005 $237 Million
Q4 2015 Nov 16, 2017	BUY	N/A	140,989 Added 3.63%	4,021,638 $238 Million
Q3 2015 Nov 16, 2017	BUY	N/A	3,880,649	3,880,649 $211 Million

Others Institutions Holding ABBV

# of Institutions

3,943

Shares Held

1.26B

Call Options Held

16.8M

Put Options Held

12.1M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $337B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aristotle Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aristotle Capital Management, LLC with notifications on news.

Account

Aristotle Capital Management, LLC Abb Vie Inc. Transaction History